Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Cutis
|
July 4, 2002
A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris
Guy F Webster, Lyn Guenther, Yves P Poulin, et al.
JAMA Dermatology
|
November 19, 2015
Safe Use of Therapeutic-Dose Oral Isotretinoin in Patients With a History of Pseudotumor Cerebri
Suzanne J Tintle, Julie C Harper, Guy F Webster, et al.
Cutis
|
September 19, 2009
Current approach to acne management: a community-based analysis
James Q Del Rosso, Hilary Baldwin, Jonette Keri, et al.
Journal of the American Academy of Dermatology
|
March 21, 2007
Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea
James Q Del Rosso, Guy F Webster, Mark Jackson, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
January 4, 2007
Pigmented Bowen's disease clinically mimicking melanoma of the nail
Aradhna Saxena, David A Kasper, Carmen D Campanelli, et al.
Seminars in Cutaneous Medicine and Surgery
|
July 9, 2010
Acne epidemiology and pathophysiology
Sheila F Friedlander, Lawrence F Eichenfield, Joseph F Fowler, et al.
Seminars in Cutaneous Medicine and Surgery
|
July 9, 2010
Perspectives on therapeutic options for acne: an update
Lawrence F Eichenfield, Joseph F Fowler, Richard G Fried, et al.
Seminars in Cutaneous Medicine and Surgery
|
July 9, 2010
Medical and psychosocial impact of acne
Richard G Fried, Guy F Webster, Lawrence F Eichenfield, et al.
Cutis
|
July 31, 2003
Current concepts in the treatment of acne: report from a clinical roundtable
Diane S Berson, Daniel K Chalker, Julie C Harper, et al.
Cutis
|
September 12, 2009
Standard management options for rosacea, part 1: overview and broad spectrum of care
Richard Odom, Mark Dahl, Jeffrey Dover, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Cutis
|
July 4, 2002
A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris
Guy F Webster, Lyn Guenther, Yves P Poulin, et al.
JAMA Dermatology
|
November 19, 2015
Safe Use of Therapeutic-Dose Oral Isotretinoin in Patients With a History of Pseudotumor Cerebri
Suzanne J Tintle, Julie C Harper, Guy F Webster, et al.
Cutis
|
September 19, 2009
Current approach to acne management: a community-based analysis
James Q Del Rosso, Hilary Baldwin, Jonette Keri, et al.
Journal of the American Academy of Dermatology
|
March 21, 2007
Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea
James Q Del Rosso, Guy F Webster, Mark Jackson, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
January 4, 2007
Pigmented Bowen's disease clinically mimicking melanoma of the nail
Aradhna Saxena, David A Kasper, Carmen D Campanelli, et al.
Seminars in Cutaneous Medicine and Surgery
|
July 9, 2010
Acne epidemiology and pathophysiology
Sheila F Friedlander, Lawrence F Eichenfield, Joseph F Fowler, et al.
Seminars in Cutaneous Medicine and Surgery
|
July 9, 2010
Perspectives on therapeutic options for acne: an update
Lawrence F Eichenfield, Joseph F Fowler, Richard G Fried, et al.
Seminars in Cutaneous Medicine and Surgery
|
July 9, 2010
Medical and psychosocial impact of acne
Richard G Fried, Guy F Webster, Lawrence F Eichenfield, et al.
Cutis
|
July 31, 2003
Current concepts in the treatment of acne: report from a clinical roundtable
Diane S Berson, Daniel K Chalker, Julie C Harper, et al.
Cutis
|
September 12, 2009
Standard management options for rosacea, part 1: overview and broad spectrum of care
Richard Odom, Mark Dahl, Jeffrey Dover, et al.
Page
of 5